| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.047 | 0.4 |